Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Judo Bio has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
Judo Bio's investors include TCG, The Column Group, Digitalis Ventures, Atlas Venture, Alexandria Venture Investments.
Judo Bio is headquartered in Cambridge, United States.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Judo Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Judo Bio — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/judo-bio. Accessed August 14, 2026.
VCBacked. (2024). Judo Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/judo-bio
{{cite web |title=Judo Bio — Funding & Investors |url=https://www.vcbacked.co/company/judo-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated